Clinical Study of Pain Reduction by Peri-arthroscopic PRP Application in Knee Degeneration (PRP-Bochum)
Primary Purpose
Knee Osteoarthritis, Cartilage Damage, Meniscal Tear
Status
Completed
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
Platelet rich plasma
Sponsored by
About this trial
This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Platelet rich plasma, Autologous conditioned plasma, Outerbridge
Eligibility Criteria
inclusion Criteria:
- degenerative knee pain
- age: > 18 years
- informed consent
- none to moderate comorbidity
- arthroscopy under general anaesthesia indicated
exclusion Criteria:
- trauma of the knee within the last 6 weeks before surgery
- circumscribed cartilage lesion with possibility of repair microfracture or autologous chondrocyte transplantation - procedures
- contraindications against PRP. application
- malignancies
- severe comorbidities
- age <18 years
- physically or mentally not able to provide informed consent
- severe knee instability
- corticosteroid injections within the last 6 weeks before surgery
Sites / Locations
- Department of Orthopaedics at the St. Josef- Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
PRP
Control
Arm Description
one intraoperative application of PRP in the interventional group
No application of any substance during knee arthroscopy
Outcomes
Primary Outcome Measures
pain ( VAS )
measurement of pain using a 100 mm VAS as platelet- rich-plasma demonstrated temporarily analgetic effects up to 6-9 months after application.
Secondary Outcome Measures
pain ( VAS )
To investigate the pain development over the follow up period at the beginning and the end of our trial
knee function (Lysholm-score )
to determine PRP-related gain of function according to time after application
quality of life ( physical und mental summaries of SF-36 German version )
to identify a possible effect of PRP application on life quality ( physical and mental summaries )
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02189408
Brief Title
Clinical Study of Pain Reduction by Peri-arthroscopic PRP Application in Knee Degeneration
Acronym
PRP-Bochum
Official Title
Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months
Study Type
Interventional
2. Study Status
Record Verification Date
July 2014
Overall Recruitment Status
Completed
Study Start Date
July 2010 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
December 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ruhr University of Bochum
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to investigate reduction of pain, gain of function and improvement of life quality by intraoperative applied platelet- rich- plasma ( PRP ) during knee arthroscopy for degeneration and osteoarthritis OA by conducting a randomized- controlled, double-blinded trial ( RCT ) including 58 patients with a follow up of 12 months and pain, assessed by Visual- Analogue Scale (VAS) after 6 months as primary endpoint.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis, Cartilage Damage, Meniscal Tear
Keywords
Platelet rich plasma, Autologous conditioned plasma, Outerbridge
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
58 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PRP
Arm Type
Experimental
Arm Description
one intraoperative application of PRP in the interventional group
Arm Title
Control
Arm Type
No Intervention
Arm Description
No application of any substance during knee arthroscopy
Intervention Type
Biological
Intervention Name(s)
Platelet rich plasma
Other Intervention Name(s)
ACP ( Arthrex )
Primary Outcome Measure Information:
Title
pain ( VAS )
Description
measurement of pain using a 100 mm VAS as platelet- rich-plasma demonstrated temporarily analgetic effects up to 6-9 months after application.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
pain ( VAS )
Description
To investigate the pain development over the follow up period at the beginning and the end of our trial
Time Frame
6 weeks, 12 months
Title
knee function (Lysholm-score )
Description
to determine PRP-related gain of function according to time after application
Time Frame
6 weeks, 6 months, 12 months
Title
quality of life ( physical und mental summaries of SF-36 German version )
Description
to identify a possible effect of PRP application on life quality ( physical and mental summaries )
Time Frame
6 weeks, 6 months and 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
inclusion Criteria:
degenerative knee pain
age: > 18 years
informed consent
none to moderate comorbidity
arthroscopy under general anaesthesia indicated
exclusion Criteria:
trauma of the knee within the last 6 weeks before surgery
circumscribed cartilage lesion with possibility of repair microfracture or autologous chondrocyte transplantation - procedures
contraindications against PRP. application
malignancies
severe comorbidities
age <18 years
physically or mentally not able to provide informed consent
severe knee instability
corticosteroid injections within the last 6 weeks before surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph von Schulze Pellengahr, MD
Organizational Affiliation
Department of Orthopaedics, University Clinic of the Ruhr- University Bochum
Official's Role
Study Director
Facility Information:
Facility Name
Department of Orthopaedics at the St. Josef- Hospital
City
Bochum
ZIP/Postal Code
44791
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
25957981
Citation
Duif C, Vogel T, Topcuoglu F, Spyrou G, von Schulze Pellengahr C, Lahner M. Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial. Arch Orthop Trauma Surg. 2015 Jul;135(7):971-7. doi: 10.1007/s00402-015-2227-5. Epub 2015 May 10.
Results Reference
derived
Learn more about this trial
Clinical Study of Pain Reduction by Peri-arthroscopic PRP Application in Knee Degeneration
We'll reach out to this number within 24 hrs